Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07154719 · ClinicalTrials.gov registry record · Phase 4
GLP-1R Actions on Muscle and the Skeleton
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT07154719 is a Phase 4 study that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 50 participants.
The verdict
NCT07154719, a Phase 4 study, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The GRAMS study objectives are to assess the musculoskeletal changes that occur after weight loss using GLP-1 based therapy. A lifestyle intervention with diet and exercise is included to assess any mitigating effects are provided, versus a control group with regular exercise and diet.
Interventions
- DRUG Tirzepatide
- BEHAVIORAL Lifestyle toolkit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-09 |
| Est. Completion | 2027-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07154719
The ClinicalTrials.gov registry entry for NCT07154719 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tirzepatide is the first listed.
NCT07154719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07154719 about?
NCT07154719 is a clinical study titled "GLP-1R Actions on Muscle and the Skeleton". The GRAMS study objectives are to assess the musculoskeletal changes that occur after weight loss using GLP-1 based therapy. A lifestyle intervention with diet and exercise is included to assess any mitigating effects are provided, versus a control group with regular exercise and diet.
What is the current status of trial NCT07154719?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2025-10-09. Estimated completion is 2027-05-01.
What interventions are being tested in trial NCT07154719?
The interventions under investigation include: Tirzepatide (DRUG), Lifestyle toolkit (BEHAVIORAL).
Who is sponsoring clinical trial NCT07154719?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.